BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25849894)

  • 1. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.
    Marano G; Vaglio S; Pupella S; Facco G; Calizzani G; Candura F; Liumbruno GM; Grazzini G
    Blood Transfus; 2015 Apr; 13(2):184-96. PubMed ID: 25849894
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transmission of parvovirus B19 by blood and blood components].
    Schwarz TF
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():27-31. PubMed ID: 8000251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?
    Mosley JW
    Transfusion; 1994 Sep; 34(9):744-6. PubMed ID: 8091460
    [No Abstract]   [Full Text] [Related]  

  • 4. Parvovirus B19 and blood products.
    Guillaume T
    Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909118
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):944-56. PubMed ID: 20853092
    [No Abstract]   [Full Text] [Related]  

  • 6. Parvovirus B19 and blood products.
    Prowse CV
    Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909119
    [No Abstract]   [Full Text] [Related]  

  • 7. Parvovirus B19: an expanding spectrum of disease.
    Cohen B
    BMJ; 1995 Dec; 311(7019):1549-52. PubMed ID: 8520401
    [No Abstract]   [Full Text] [Related]  

  • 8. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
    Lefrère JJ; Mariotti M; Thauvin M
    Lancet; 1994 Jan; 343(8891):211-2. PubMed ID: 7904670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat sensitivity of human parvovirus B19.
    Yunoki M; Tsujikawa M; Urayama T; Sasaki Y; Morita M; Tanaka H; Hattori S; Takechi K; Ikuta K
    Vox Sang; 2003 Apr; 84(3):164-9. PubMed ID: 12670364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 infection.
    Kerr JR
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):10-29. PubMed ID: 8641299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating parvovirus B19 from blood products.
    Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M
    Lancet; 1994 Mar; 343(8900):798. PubMed ID: 7907759
    [No Abstract]   [Full Text] [Related]  

  • 12. Human parvoviruses: implications for transfusion medicine.
    Luban NL
    Transfusion; 1994 Sep; 34(9):821-7. PubMed ID: 8091474
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of a candidate parvovirus B19 vaccine.
    Bernstein DI; El Sahly HM; Keitel WA; Wolff M; Simone G; Segawa C; Wong S; Shelly D; Young NS; Dempsey W
    Vaccine; 2011 Oct; 29(43):7357-63. PubMed ID: 21807052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parvovirus B19.
    Am J Transplant; 2004 Nov; 4 Suppl 10():92-4. PubMed ID: 15504221
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of human parvovirus B19 DNA contamination of factor VIII products.
    Matsunaga Y
    Dev Biol Stand; 1996; 88():217. PubMed ID: 9119140
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent.
    Koliou M; Karaoli E; Soteriades ES; Pavlides S; Bashiardes S; Christodoulou C
    BMC Pediatr; 2014 Jan; 14():6. PubMed ID: 24410941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 in pregnancy.
    McCarter-Spaulding D
    J Obstet Gynecol Neonatal Nurs; 2002; 31(1):107-12. PubMed ID: 11843014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus-6 and parvovirus B19 infections in children.
    Asano Y; Yoshikawa T
    Curr Opin Pediatr; 1993 Feb; 5(1):14-20. PubMed ID: 8397041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood donor screening for parvovirus B19 in Germany and Austria.
    Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
    Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
    Yee TT; Cohen BJ; Pasi KJ; Lee CA
    Br J Haematol; 1996 May; 93(2):457-9. PubMed ID: 8639448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.